Discussing MDMA

Jarryd Bartle, Nicole Lee & Paula Ross

writer

Jarryd Bartle, Nicole Lee & Paula Ross

Sessional Lecturer, RMIT University | Professor at the National Drug Research Institute (Melbourne), Curtin University | Sessional psychology lecturer, Australian Catholic University

We all want to reduce drug-related harm and ensure young people don’t take unnecessary risks. But decades of research shows fear isn’t an effective way to do this.

This week, Newscorp Australia released The Ripple Effect, a series of articles and accompanying videos about party drugs, aimed at parents of young people.

Rather than drawing on the science about reducing harm, the series overstates the nation’s drug problem and the likelihood of problems from taking MDMA (ecstasy). And it’s likely to scare the wits out of parents of teens.

So, what do parents really need to know about party drugs?

Most young people don’t use drugs

Illicit drug use among teens is low and has been in decline for nearly a decade.

Although Australians overall have a relatively high rate of MDMA use compared to similar countries, only a small proportion of teenagers (around 3%) and young adults (7%) have used MDMA in the last year. Among high school students, the overwhelming majority (94%) have never tried MDMA.

Normalising the idea that drug use isn’t that common is a key prevention strategy in drug education. If young people think “everyone” is using drugs, they are more likely to want to do it too.

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Scientia Prof Kaarin Anstey

Scientia Prof Kaarin Anstey

New Brain Health Guidelines – What GPs Can Do

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism & Mental Health Comorbidities

Dr Rebecca Purvis

Dr Rebecca Purvis

Pharmacogenomics in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Jarryd Bartle, Nicole Lee & Paula Ross

writer

Jarryd Bartle, Nicole Lee & Paula Ross

Sessional Lecturer, RMIT University | Professor at the National Drug Research Institute (Melbourne), Curtin University | Sessional psychology lecturer, Australian Catholic University

Test your knowledge

Recent articles

Latest GP poll

In the last twelve months, how many adverse outcomes have you encountered arising from pharmacy prescribing?

None

0%

1-2

0%

Three or more

0%

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.